BSE - Delayed Quote INR

Thirumalai Chemicals Limited (TIRUMALCHM.BO)

278.70

+6.90

+(2.54%)

At close: April 17 at 3:29:42 PM GMT+5:30

Television could go the way of newspapers if the US economy tips into recession, analyst warns

Trump's sweeping new tariffs have reignited recession fears, with analysts warning that a resulting pullback in ad spending could wipe out $45 billion from the US market — and potentially accelerate the decline of traditional TV.

Yahoo Finance 1 hour ago

ROKU

NFLX

DIS
Is Netflix (NFLX) Among the Best WallStreetBets Stocks to Buy According to Hedge Funds?

We recently published a list of 12 Best WallStreetBets Stocks To Buy According to Hedge Funds. In this article, we are going to take a look at where Netflix, Inc. (NASDAQ:NFLX) stands against other best WallStreetBets stocks to buy according to hedge funds. The World Economic Forum’s Global Retail Investor Outlook 2024 highlighted a sustained transition towards […]

Insider Monkey 8 minutes ago

NFLX
These 7 Stocks Are Analyst Favorites For Magnificent Earnings Growth

Netflix and DoorDash are two of the seven best stocks where investors can find magnificent profit growth prospects. More than 70% of analysts covering Netflix have buy or overweight ratings on the video streaming service. The consensus estimate for 2025 earnings is $24.76, a 21% increase from last year, according to FactSet.

Investor's Business Daily 2 hours ago

ISRG

NFLX

LLY
Retirees, Now’s Not the Time to Buy the Dip

The S&P 500 has entered correction territory, and investors may be wondering if it’s a good time to scoop up shares that have gone on sale. For retirees, the answer is: probably not.

Barrons.com 2 hours ago

NVDA

^GSPC
Riot Platforms (RIOT): Among Jeff Smith’s Top Activist Targets

We recently published a list of Jeff Smith’s Top 10 Activist Targets and Their Returns Compared to the S&P 500. In this article, we are going to take a look at where Riot Platforms, Inc. (NASDAQ:RIOT) stands against other Jeff Smith’s top activist targets. Jeff Smith is arguably the “most feared man” in corporate America, […]

Insider Monkey 4 hours ago

^GSPC
Healthcare Realty Trust (HR): Among Jeff Smith’s Top Activist Targets

We recently published a list of Jeff Smith’s Top 10 Activist Targets and Their Returns Compared to the S&P 500. In this article, we are going to take a look at where Healthcare Realty Trust Incorporated (NYSE:HR) stands against other Jeff Smith’s top activist targets. Jeff Smith is arguably the “most feared man” in corporate […]

Insider Monkey 4 hours ago

HR

^GSPC
Kenvue Inc. (KVUE): Among Jeff Smith’s Top Activist Targets

We recently published a list of Jeff Smith’s Top 10 Activist Targets and Their Returns Compared to the S&P 500. In this article, we are going to take a look at where Kenvue Inc. (NYSE:KVUE) stands against other Jeff Smith’s top activist targets. Jeff Smith is arguably the “most feared man” in corporate America, having […]

Insider Monkey 4 hours ago

KVUE

^GSPC
Pfizer Inc. (PFE): Among Jeff Smith’s Top Activist Targets

We recently published a list of Jeff Smith’s Top 10 Activist Targets and Their Returns Compared to the S&P 500. In this article, we are going to take a look at where Pfizer Inc. (NYSE:PFE) stands against other Jeff Smith’s top activist targets. Jeff Smith is arguably the “most feared man” in corporate America, having […]

Insider Monkey 4 hours ago

PFE

^GSPC
News Corporation (NWS): Among Jeff Smith’s Top Activist Targets

We recently published a list of Jeff Smith’s Top 10 Activist Targets and Their Returns Compared to the S&P 500. In this article, we are going to take a look at where News Corporation (NASDAQ:NWS) stands against other Jeff Smith’s top activist targets. Jeff Smith is arguably the “most feared man” in corporate America, having […]

Insider Monkey 4 hours ago

NWSA

^GSPC
GoDaddy Inc. (GDDY): Among Jeff Smith’s Top Activist Targets

We recently published a list of Jeff Smith’s Top 10 Activist Targets and Their Returns Compared to the S&P 500. In this article, we are going to take a look at where GoDaddy Inc. (NYSE:GDDY) stands against other Jeff Smith’s top activist targets. Jeff Smith is arguably the “most feared man” in corporate America, having […]

Insider Monkey 4 hours ago

GDDY

^GSPC
Capital One receives final regulatory approvals for acquisition of Discover

Capital One Financial (COF) and Discover Financial Services (DFS) announced that the Board of Governors of the Federal Reserve System and the Office of the Comptroller of the Currency have approved Capital One’s proposed acquisition of Discover. This approval follows approval of the transaction by the Delaware State Bank Commissioner in December 2024, and by shareholders of more than 99% of each company’s shares voting in February of this year. All required regulatory approvals to complete the t

TipRanks 4 hours ago

DFS

COF

COF-PK
A Once-in-a-Decade Opportunity: 3 Magnificent Stocks Down Between 40% and 73% to Buy Right Now

Zoetis (NYSE: ZTS) is a leading animal healthcare company offering over 300 medicines, vaccines, and other precision health products to care for companion animals and livestock globally. Since its spin-off from Pfizer in 2013, Zoetis has delivered an annualized total return of 15%, demonstrating the market-beating potential of what might look like a steady-Eddie investment at first glance. Following this decline, though, Zoetis now trades at a price-to-earnings (P/E) ratio of 27 -- its lowest mark in a decade.

Motley Fool 5 hours ago

ZTS

WING

YETI
Billionaire fund manager makes bold bets on Meta, Nvidia stock

The veteran hedge fund manager's latest tech stock trades turn heads.

TheStreet 5 hours ago

NVDA

META

^GSPC
3 Magnificent Stocks to Buy That Are Near 52-Week Lows

It's been a tough start to 2025 for investors amid concerns regarding the strength of the U.S. economy and uncertainties over the effect of sweeping changes in trade policy under the Trump administration. Zoetis (NYSE: ZTS) is a global leader in animal health, with an extensive portfolio of medicines, vaccines, and diagnostic products for livestock and pets. The company's diversification, covering 17 products generating over $100 million in annual revenue, including several best-in-class treatments, underscores its appeal as an investment.

Motley Fool 7 hours ago

ZTS

PFE

NKE
2 No-Brainer Vanguard ETFs to Buy With $1,000 Right Now

One of my favorite ways to invest is through exchange-traded funds (ETFs) because they offer you to exposure to many companies with a single investment. With everything going on in the stock market right now (tariff reactions, high volatility, recession fears), ETFs can be especially useful because they're less risky than individual stocks and provide built-in diversification. If you have an emergency fund saved and high-interest debt paid down (like credit cards), these two Vanguard ETFs are worth considering.

Motley Fool 9 hours ago

^GSPC
Netflix price target raised to $1,000 from $900 at Barclays

Barclays raised the firm’s price target on Netflix (NFLX) to $1,000 from $900 and keeps an Equal Weight rating on the shares. Netflix has come to be seen as a “defensive long” in the current macro backdrop and its Q1 results and Q2 guidance “are likely to reinforce this thesis further,” the analyst tells investors in a research note. The firm says that while the company’s revenue was roughly in line with consensus, margin for the quarter and margin guidance for Q2 were both better than estimates

TipRanks 9 hours ago

NFLX
Netflix price target raised to $1,200 from $1,175 at BMO Capital

BMO Capital raised the firm’s price target on Netflix (NFLX) to $1,200 from $1,175 and keeps an Outperform rating on the shares following the Q1 report. Netflix effectively launched its Ad Suite in the U.S. on April 1, with an international ramp beginning in Q2, and management reiterated a two-times increase in advertising revenue growth in 2025, the analyst tells investors in a research note. The firm believes the company’s ad tier will continue to scale, driven by engagement growth, pricing le

TipRanks 9 hours ago

NFLX
Netflix price target raised to $1,150 from $1,100 at Guggenheim

Guggenheim analyst Michael Morris raised the firm’s price target on Netflix (NFLX) to $1,150 from $1,100 and keeps a Buy rating on the shares. The company reported “solid” Q1 results, headlined by a profitability beat, with outperformance benefiting from revenue ahead of guidance and expense timing, the analyst tells investors in a research note. The firm says Netflix’s Q2 guidance was similarly ahead of consensus estimates. It sees a “long runway for growth.” Published first on TheFly – the ult

TipRanks 9 hours ago

NFLX
Netflix price target raised to $1,200 from $1,150 at Oppenheimer

Oppenheimer raised the firm’s price target on Netflix (NFLX) to $1,200 from $1,150 and keeps an Outperform rating on the shares following the Q1 report. The company’s U.S. pricing increase has been well-received, with no churn increase or downgrading plans, the analyst tells investors in a research note. The firm says that despite the uncertain macro environment, increasing prices in France support confidence in Netflix’s business resilience. It attributes he Q1 beat to advertising and subscript

TipRanks 9 hours ago

NFLX
Netflix price target raised to $1,150 from $1,100 at MoffettNathanson

MoffettNathanson analyst Robert Fishman raised the firm’s price target on Netflix (NFLX) to $1,150 from $1,100 and keeps a Buy rating on the shares. Despite the Q1 beat relative to guidance, Netflix maintained its 2025 guidance across the board, the analyst tells investors in a research note. The firm continues to forecast Netflix generating nearly $6B in advertising revenue in 2027 and $9.6B by 2030. It believes the company appears to be underearning relative to its engagement and even after th

TipRanks 9 hours ago

NFLX

Performance Overview

Return	TIRUMALCHM.BO	S&P BSE SENSEX (^BSESN)
YTD	-13.22%	+0.53%
1-Year	-0.31%	+7.69%
3-Year	-7.61%	+34.65%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Thirumalai Chemicals Limited (TIRUMALCHM.BO)

Related News

Television could go the way of newspapers if the US economy tips into recession, analyst warns

Is Netflix (NFLX) Among the Best WallStreetBets Stocks to Buy According to Hedge Funds?

These 7 Stocks Are Analyst Favorites For Magnificent Earnings Growth

Retirees, Now’s Not the Time to Buy the Dip

Riot Platforms (RIOT): Among Jeff Smith’s Top Activist Targets

Healthcare Realty Trust (HR): Among Jeff Smith’s Top Activist Targets

Kenvue Inc. (KVUE): Among Jeff Smith’s Top Activist Targets

Pfizer Inc. (PFE): Among Jeff Smith’s Top Activist Targets

News Corporation (NWS): Among Jeff Smith’s Top Activist Targets

GoDaddy Inc. (GDDY): Among Jeff Smith’s Top Activist Targets

Capital One receives final regulatory approvals for acquisition of Discover

A Once-in-a-Decade Opportunity: 3 Magnificent Stocks Down Between 40% and 73% to Buy Right Now

Billionaire fund manager makes bold bets on Meta, Nvidia stock

3 Magnificent Stocks to Buy That Are Near 52-Week Lows

2 No-Brainer Vanguard ETFs to Buy With $1,000 Right Now

Netflix price target raised to $1,000 from $900 at Barclays

Netflix price target raised to $1,200 from $1,175 at BMO Capital

Netflix price target raised to $1,150 from $1,100 at Guggenheim

Netflix price target raised to $1,200 from $1,150 at Oppenheimer

Netflix price target raised to $1,150 from $1,100 at MoffettNathanson

Performance Overview